CYTOVALE Trademark

Trademark Overview


On Friday, June 5, 2020, a trademark application was filed for CYTOVALE with the United States Patent and Trademark Office. The USPTO has given the CYTOVALE trademark a serial number of 88950318. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 11, 2023. This trademark is owned by Cytovale Inc.. The CYTOVALE trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology

medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diag...
cytovale

General Information


Serial Number88950318
Word MarkCYTOVALE
Filing DateFriday, June 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements


Goods and Servicesmedical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology
Goods and Servicesmedical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diagnostic apparatus for medical use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical testing kits for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis, automatic cell sorting systems comprised of single-cell analysis, optical detection modalities, electrical detection modalities, mechanical detection modalities for use in flow cytometry analysis and in fluorescence activated cell sorting; flow cytometers

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 29, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 29, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCytovale Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94134

Party NameCytovale Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94134

Trademark Events


Event DateEvent Description
Tuesday, June 9, 2020NEW APPLICATION ENTERED
Monday, June 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 9, 2020ASSIGNED TO EXAMINER
Tuesday, September 15, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 15, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 20, 2021FINAL REFUSAL WRITTEN
Saturday, February 20, 2021FINAL REFUSAL E-MAILED
Saturday, February 20, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 12, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, August 12, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, August 12, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, August 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 2, 2022TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 2, 2022DIVISIONAL REQUEST RECEIVED
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 9, 2022SOU EXTENSION 1 FILED
Saturday, May 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 19, 2022DIVISIONAL PROCESSING COMPLETE
Thursday, May 19, 2022SOU EXTENSION 1 GRANTED
Friday, May 20, 2022CORRECTED NOA E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 2 FILED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 8, 2023SOU EXTENSION 3 FILED
Friday, November 4, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Monday, May 8, 2023SOU EXTENSION 3 GRANTED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 11, 2023ABANDONMENT - NO USE STATEMENT FILED